EGFR-IN-93 (compound 18) is an allosteric inhibitor of the T790M/L858R double mutant EGFR. It is applicable for research in non-small cell lung cancer (NSCLC).
Formula:
C22H18FN3O3
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted